Manfriday Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
- Paid Up Capital ₹ 0.10 M
- Company Age 12 Year, 5 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 9.00 M
- Revenue Growth -14.33%
- Profit Growth -15.23%
- Ebitda -99.59%
- Net Worth 9.59%
- Total Assets 38.29%
About Manfriday Lifesciences
Manfriday Lifesciences Private Limited (MLPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 18 February 2013 and has a history of 12 years. Its registered office is in North Delhi, Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹9.00 M.
Poonam and Rakesh Aneja serve as directors at the Company.
Company Details
- Location
North Delhi, Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74999DL2013PTC248416
- Company No.
248416
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Feb 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
What products or services does Manfriday Lifesciences Private Limited offer?
Manfriday Lifesciences Private Limited offers a wide range of products and services, including Vitamin Tablets & Capsules, Methylcobalamin Tablets, Antibiotic Injection, Tazobactam Injection, Meropenem Injection, Pharmaceutical Syrup, Dry Syrups, Pharmaceutical Medicine, Antihistamines, Diphenhydramine Pharmaceutical Syrup.
Who are the key members and board of directors at Manfriday Lifesciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Poonam  | Director | 18-Feb-2013 | Current |
| Rakesh Aneja | Director | 18-Feb-2013 | Current |
Financial Performance of Manfriday Lifesciences.
Manfriday Lifesciences Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 14.33% decrease. The company also saw a substantial fall in profitability, with a 15.23% decrease in profit. The company's net worth moved up by a moderate rise of 9.59%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Manfriday Lifesciences?
Unlock access to Manfriday Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹9.00 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.90 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Jul 2020 | Others | ₹9.00 M | Open |
How Many Employees Work at Manfriday Lifesciences?
Unlock and access historical data on people associated with Manfriday Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Manfriday Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Manfriday Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.